The lessons of Vioxx - Drug safety and sales

被引：78

作者：

Waxman, HA

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 352卷 / 25期

关键词：

D O I：

10.1056/NEJMp058136

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：2576 / 2578

页数：3

相关论文

共 5 条

[1] National trends in cyclooxygenase-2 inhibitor use since market release - Nonselective diffusion of a selectively cost-effective innovation [J].

Dai, CL ;

Stafford, RS ;

Alexander, C .

ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (02) :171-177

[2]

*FDA ADV COMM, 2001, 21042S007 NDA FDA AD

[3] Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study [J].

Graham, DJ ;

Campen, D ;

Hui, R ;

Spence, M ;

Cheetham, C ;

Levy, G ;

Shoor, S ;

Graham, D .

LANCET, 2005, 365 (9458) :475-481

[4]

ROSE JL, 2002, PHYS EXPECTATIONS IN

[5]

*US HOUS REPR COMM, MERCK DOC SHOW AGGR